ANGLE (LON:AGL) Stock Passes Below Two Hundred Day Moving Average – Should You Sell?

ANGLE plc (LON:AGL)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 2.75 and traded as low as GBX 2.33. ANGLE shares last traded at GBX 2.35, with a volume of 1,682,496 shares changing hands.

ANGLE Stock Performance

The company has a 50 day moving average price of GBX 2.35 and a two-hundred day moving average price of GBX 2.75. The company has a debt-to-equity ratio of 31.35, a quick ratio of 6.18 and a current ratio of 3.13. The firm has a market capitalization of £7.58 million, a price-to-earnings ratio of -0.49 and a beta of 0.22.

About ANGLE

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.